VRDN 424B5: Secondary offering
Filed with the SEC on · accession 0001193125-26-214614
VRDN filed a 424B5 (prospectus (offering)) with the SEC on May 8, 2026. Viridian Therapeutics is offering $225 million aggregate principal amount of 1.75% convertible senior notes due 2032, with an underwriter option for an additional $25 million. The stock moved -2.3% by the first close after the filing.
Summary of the filing
Viridian Therapeutics is offering $225 million aggregate principal amount of 1.75% convertible senior notes due 2032, with an underwriter option for an additional $25 million. Concurrently, the company is conducting a $125 million common stock offering.
Key details
How VRDN stock reacted
Close before
$17.00
May 7, 2026
First close after
-2.29%
$16.61
5 trading days
+2.53%
$17.43
Since filing
+67.59%
$28.49
✦ Ask GOAX AI about this filing — what it means for VRDN, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for VRDN?
Click hereFrequently asked questions
What did VRDN file with the SEC on May 8, 2026?
VRDN filed a 424B5 (Secondary offering). Viridian Therapeutics is offering $225 million aggregate principal amount of 1.75% convertible senior notes due 2032, with an underwriter option for an additional $25 million. Concurrently, the company is conducting a $125 million common stock offering.
What does a secondary offering mean for VRDN stock?
New shares dilute existing holders and are often sold at a discount to the market price.
How do I read a 424B5?
The final terms of an offering of shares or bonds. Look at price, number of shares and the discount to the market price. Large offerings dilute existing shareholders.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 424B5 (prospectus (offering)): The final terms of an offering of shares or bonds.
How did VRDN stock react to this filing?
VRDN closed at $17.00 before the filing and $16.61 on May 8, 2026 (-2.29%). Five trading days later: $17.43 (+2.53%).
Other VRDN SEC filings
- 10-Q · SEC filingNov 4, 2026
- 8-K · SEC filingNov 4, 2026
- SCHEDULE 13G · SEC filingAug 20, 2026
- SCHEDULE 13G/A · SEC filingAug 14, 2026
- SCHEDULE 13G · SEC filingAug 14, 2026
- SCHEDULE 13G/A · SEC filingAug 14, 2026
- SCHEDULE 13G/A · SEC filingAug 14, 2026
- 10-Q · Material agreementAug 6, 2026
- 8-K · Guidance raiseAug 6, 2026
- 8-K · Fda approvalJun 29, 2026
Get alerts when VRDN files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days